Here's the argument: Americans pay loads for drugs. That motivates and funds pharmaceutical companies' research and development for better drugs. The fear is that if you lower the cost of drugs you might hurt overall innovation.
Today on the show, we speak with a health economist who argues that's not always true. In fact, she says there are a bunch of policies that could help bring down drug prices without stifling innovation.
Music by Drop Electric. Find us: Twitter / Facebook / Newsletter.
Subscribe to our show on Apple Podcasts, Spotify, Pocket Casts and NPR One.
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
2024-12-26 10:511048 view
2024-12-26 10:431141 view
2024-12-26 10:22722 view
2024-12-26 10:192596 view
2024-12-26 08:421168 view
2024-12-26 08:242535 view
Beyoncé is taking home her first country award after her eighth studio album "Cowboy Carter" garner
As Texas wildfires burned toward the nation’s primary nuclear weapons facility, workers hurried to e
If anyone thought Kate Hudson was a fool for getting married at 21, remember: even fools have their
